Shandong New Time Pharmaceutical Co., LTD
31
4
4
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 31 trials
100.0%
+13.5% vs industry average
23%
7 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (31)
Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans
Role: lead
Bioequivalence Study of Nalfurafine Hydrochloride Orally Disintegrating Tablets on Fasting and Fed in Humans
Role: lead
Bioequivalence Study of Dronedarone Hydrochloride Tablets in Healthy Subjects Under Fasting Conditions
Role: lead
Bioequivalence Study of Dronedarone Hydrochloride Tablets
Role: lead
A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Role: lead
Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes
Role: lead
A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents
Role: lead
Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria
Role: lead
A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction
Role: lead
Phase II Clinical Study of Vonorasan Fumarate Injection in the Treatment of Peptic Ulcer Bleeding
Role: lead
A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
Role: lead
A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors
Role: lead
Phase II Clinical Study of AC591 in Preventing Oxaliplatin-Induced Peripheral Neuropathy
Role: lead
A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma
Role: lead
Phase I Study of LNF1901 in Advanced Malignant Tumors
Role: lead
Phase I Study of XZ120 in Malignant Tumors
Role: lead
A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver
Role: lead
A Phase IV Study of Huazhi Rougan Granule
Role: lead
the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma
Role: lead
A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Role: lead